Literature DB >> 9630043

Low levels of serum erythropoietin in children with endemic hemolytic uremic syndrome.

R Exeni1, H Donato, P Rendo, M Antonuccio, M C Rapetti, I Grimoldi, A Exeni, A de Galvagni, E Trepacka, A Amore.   

Abstract

Serum erythropoietin (EPO) levels were measured in ten previously non-transfused children with hemolytic uremic syndrome (HUS). Complete blood cell count, serum EPO, and renal function tests were carried out upon admission and weekly thereafter. Blood samples were obtained: (1) prior to the first transfusion; (2) after the first transfusion but before recovery from renal failure; (3) during the recovery stage. All patients required transfusions (mean 1.8+/-0.8 per child). Absolute values of EPO correlated positively with the hematocrit during the three stages (r = 0.53, 0.36, and 0.12, respectively) which is opposite to expected results. The observed EPO logarithm/predicted EPO logarithm upon admission was low (0.70+/-0.08), falling further during stage 2 (0.57+/-0.03), but increasing thereafter (0.78+/-0.07) without reaching normal values. The reticulocyte production rate followed a parallel course (0.74+/-0.14, 0.54+/-0.11, and 0.60+/-0.10, respectively). On comparing the observed serum EPO levels with those expected, 9 of 11 pre-transfusion samples showed low values; in stage 2, all samples were below normal; in the recovery phase most (77.8%) were still low. Our results show an inadequate EPO synthesis in children with HUS, which could play an important pathogenic role, since it aggravates the severity of the existing hemolytic anemia; the secondary inhibitory effect of repeated transfusions exacerbates this inadequate synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630043     DOI: 10.1007/s004670050443

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  7 in total

1.  Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome.

Authors:  Carlos J Cobeñas; Paula S Bresso; Laura L Lombardi; Oscar R Amoreo; Javier D Ruscasso; Ana P Spizzirri; Ângela Del C Suarez; Javier H Zalba; Ricardo C Rahman; Paula Risso
Journal:  Pediatr Nephrol       Date:  2015-07-04       Impact factor: 3.714

2.  Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.

Authors:  Deborah J Stearns-Kurosawa; Valta Collins; Scott Freeman; Diann Debord; Kiyotaka Nishikawa; Sun-Young Oh; Caitlin S Leibowitz; Shinichiro Kurosawa
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

3.  Early erythropoietin in post-diarrheal hemolytic uremic syndrome: a case-control study.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2014-08-21       Impact factor: 3.714

4.  Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial.

Authors:  Alejandro Balestracci; Marina Andrea Capone; Luciana Meni Battaglia; Ismael Toledo; Sandra Mariel Martin; Laura Beaudoin; Jeanette Balbaryski; Lorena Gómez
Journal:  Pediatr Nephrol       Date:  2022-02-15       Impact factor: 3.651

5.  Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial.

Authors:  Lars Pape; Thurid Ahlenstiel; Martin Kreuzer; Jens Drube; Kerstin Froede; Doris Franke; Jochen H H Ehrich; Marion Haubitz
Journal:  Pediatr Nephrol       Date:  2008-12-16       Impact factor: 3.714

6.  Targeting the innate repair receptor axis via erythropoietin or pyroglutamate helix B surface peptide attenuates hemolytic-uremic syndrome in mice.

Authors:  Sophie Dennhardt; Wiebke Pirschel; Bianka Wissuwa; Diana Imhof; Christoph Daniel; Jan T Kielstein; Isabel Hennig-Pauka; Kerstin Amann; Florian Gunzer; Sina M Coldewey
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

7.  Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome.

Authors:  Da Eun Woo; Jae Min Lee; Yu Kyung Kim; Yong Hoon Park
Journal:  Korean J Pediatr       Date:  2016-02-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.